Advertisement
Screener

Voyager Therapeutics, Inc. (VYGR) Increase (Decrease) in Prepaid Expense and Other Assets

Voyager Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

Voyager Therapeutics, Inc. (VYGR) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.87M, a 30.66% decline year-over-year.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$471.00K.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$2.29M.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$3.15M, a 382.27% decline year-over-year.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$3.62M, a 237.69% decline from fiscal 2024.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.63M.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$76.00K, a 103.86% decline from fiscal 2022.
  • Voyager Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.97M.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$1.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.40M
10-Q · filed 2026-08-06
-$893.00K
derived: sum of 3 quarters · filed 2026-08-06
-$4.05M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$471.00K
10-Q · filed 2026-05-07
-$2.76M
derived: sum of 2 quarters · filed 2026-05-07
-$5.91M
derived: sum of 3 quarters · filed 2026-05-07
-$3.22M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$5.44M
derived: sum of 2 quarters · filed 2026-03-09
-$2.75M
derived: sum of 3 quarters · filed 2026-08-06
-$3.62M
10-K · filed 2026-03-09
2025-09-30-$3.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$459.00K
derived: sum of 2 quarters · filed 2026-08-06
-$1.33M
10-Q · filed 2025-11-10
-$1.80M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$2.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.83M
10-Q · filed 2026-08-06
$1.36M
derived: sum of 3 quarters · filed 2026-08-06
$2.47M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$868.00K
10-Q · filed 2026-05-07
-$1.34M
derived: sum of 2 quarters · filed 2026-05-07
-$221.00K
derived: sum of 3 quarters · filed 2026-05-07
$965.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$470.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$647.00K
derived: sum of 2 quarters · filed 2026-03-09
$1.83M
derived: sum of 3 quarters · filed 2026-03-09
$2.63M
10-K · filed 2026-03-09
2024-09-30$1.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$2.30M
derived: sum of 2 quarters · filed 2025-11-10
$3.10M
10-Q · filed 2025-11-10
$2.68M
derived: sum of 4 quarters · filed 2026-03-09
2024-06-30$1.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$1.98M
10-Q · filed 2025-08-06
$1.56M
derived: sum of 3 quarters · filed 2026-03-09
$1.22M
derived: sum of 4 quarters · filed 2026-03-09
2024-03-31$794.00K
10-Q · filed 2025-05-06
$376.00K
derived: sum of 2 quarters · filed 2026-03-09
$32.00K
derived: sum of 3 quarters · filed 2026-03-09
$2.13M
derived: sum of 4 quarters · filed 2026-03-09
2023-12-31-$418.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$762.00K
derived: sum of 2 quarters · filed 2026-03-09
$1.33M
derived: sum of 3 quarters · filed 2026-03-09
-$76.00K
10-K · filed 2026-03-09
2023-09-30-$344.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$1.75M
derived: sum of 2 quarters · filed 2024-11-12
$342.00K
10-Q · filed 2024-11-12
$657.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$686.00K
10-Q · filed 2024-08-06
$1.00M
derived: sum of 3 quarters · filed 2025-03-11
$2.66M
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31-$1.41M
10-Q · filed 2024-05-13
-$1.10M
derived: sum of 2 quarters · filed 2025-03-11
$562.00K
derived: sum of 3 quarters · filed 2025-03-11
$371.00K
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31$315.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$1.97M
derived: sum of 2 quarters · filed 2025-03-11
$1.78M
derived: sum of 3 quarters · filed 2025-03-11
$1.97M
10-K · filed 2025-03-11
2022-09-30$1.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
$1.47M
derived: sum of 2 quarters · filed 2023-11-06
$1.65M
10-Q · filed 2023-11-06
$1.50M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$191.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$6.00K
10-Q · filed 2023-08-03
-$158.00K
derived: sum of 3 quarters · filed 2024-02-28
-$996.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$185.00K
10-Q · filed 2023-05-09
$33.00K
derived: sum of 2 quarters · filed 2024-02-28
-$805.00K
derived: sum of 3 quarters · filed 2024-02-28
-$1.38M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$152.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$990.00K
derived: sum of 2 quarters · filed 2024-02-28
-$1.56M
derived: sum of 3 quarters · filed 2024-02-28
-$1.88M
10-K · filed 2024-02-28
2021-09-30-$838.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$1.41M
derived: sum of 2 quarters · filed 2022-11-08
-$1.73M
10-Q · filed 2022-11-08
$199.00K
derived: sum of 4 quarters · filed 2023-03-07
2021-06-30-$570.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$893.00K
10-Q · filed 2022-08-04
$1.04M
derived: sum of 3 quarters · filed 2023-03-07
$653.00K
derived: sum of 4 quarters · filed 2023-03-07
2021-03-31-$323.00K
10-Q · filed 2022-05-04
$1.61M
derived: sum of 2 quarters · filed 2023-03-07
$1.22M
derived: sum of 3 quarters · filed 2023-03-07
$173.00K
derived: sum of 4 quarters · filed 2023-03-07
2020-12-31$1.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07
$1.55M
derived: sum of 2 quarters · filed 2023-03-07
$496.00K
derived: sum of 3 quarters · filed 2023-03-07
$551.00K
10-K · filed 2023-03-07
2020-09-30-$384.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
-$1.43M
derived: sum of 2 quarters · filed 2021-11-02
-$1.38M
10-Q · filed 2021-11-02
-$3.00M
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30-$1.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$995.00K
10-Q · filed 2021-08-09
-$2.62M
derived: sum of 3 quarters · filed 2022-03-08
$296.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31$55.00K
10-Q · filed 2021-05-10
-$1.57M
derived: sum of 2 quarters · filed 2022-03-08
$1.35M
derived: sum of 3 quarters · filed 2022-03-08
-$1.61M
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31-$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$1.29M
derived: sum of 2 quarters · filed 2022-03-08
-$1.67M
derived: sum of 3 quarters · filed 2022-03-08
-$1.68M
10-K · filed 2022-03-08
2019-09-30$2.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$45.00K
derived: sum of 2 quarters · filed 2020-11-09
-$52.00K
10-Q · filed 2020-11-09
$3.76M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$2.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$2.97M
10-Q · filed 2020-08-10
$844.00K
derived: sum of 3 quarters · filed 2021-02-25
-$413.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$7.00K
10-Q · filed 2020-05-06
$3.80M
derived: sum of 2 quarters · filed 2021-02-25
$2.55M
derived: sum of 3 quarters · filed 2021-02-25
$4.24M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$2.55M
derived: sum of 2 quarters · filed 2021-02-25
$4.24M
derived: sum of 3 quarters · filed 2021-02-25
$3.94M
10-K · filed 2021-02-25
2018-09-30-$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$432.00K
derived: sum of 2 quarters · filed 2019-11-06
$127.00K
10-Q · filed 2019-11-06
$261.00K
derived: sum of 4 quarters · filed 2020-03-03
2018-06-30$1.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$1.38M
10-Q · filed 2019-08-09
$1.52M
derived: sum of 3 quarters · filed 2020-03-03
$719.00K
derived: sum of 4 quarters · filed 2020-03-03
2018-03-31-$305.00K
10-Q · filed 2019-05-07
-$171.00K
derived: sum of 2 quarters · filed 2020-03-03
-$970.00K
derived: sum of 3 quarters · filed 2020-03-03
-$977.00K
derived: sum of 4 quarters · filed 2020-03-03
2017-12-31$134.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03
-$665.00K
derived: sum of 2 quarters · filed 2020-03-03
-$672.00K
derived: sum of 3 quarters · filed 2020-03-03
-$1.63M
10-K · filed 2020-03-03
2017-09-30-$799.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$806.00K
derived: sum of 2 quarters · filed 2018-11-07
-$1.76M
10-Q · filed 2018-11-07
-$1.23M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$965.00K
10-Q · filed 2018-08-07
-$429.00K
derived: sum of 3 quarters · filed 2019-02-26
-$45.00K
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$958.00K
10-Q · filed 2018-05-10
-$422.00K
derived: sum of 2 quarters · filed 2019-02-26
-$38.00K
derived: sum of 3 quarters · filed 2019-02-26
-$260.00K
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$536.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$920.00K
derived: sum of 2 quarters · filed 2019-02-26
$698.00K
derived: sum of 3 quarters · filed 2019-02-26
$847.00K
10-K · filed 2019-02-26
2016-09-30$384.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$162.00K
derived: sum of 2 quarters · filed 2017-11-02
$311.00K
10-Q · filed 2017-11-02
-$311.00K
10-Q · filed 2016-11-10
$302.00K
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$222.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$73.00K
10-Q · filed 2017-08-08
$73.00K
10-Q · filed 2016-08-11
-$82.00K
derived: sum of 3 quarters · filed 2018-03-14
-$451.00K
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$149.00K
10-Q · filed 2017-05-09
-$149.00K
10-Q · filed 2016-05-12
$140.00K
derived: sum of 2 quarters · filed 2018-03-14
-$229.00K
derived: sum of 3 quarters · filed 2018-03-14
-$111.00K
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$9.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$378.00K
derived: sum of 2 quarters · filed 2018-03-14
-$260.00K
derived: sum of 3 quarters · filed 2018-03-14
$234.00K
10-K · filed 2018-03-14
-$234.00K
10-K · filed 2016-03-17
2015-09-30-$369.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$251.00K
derived: sum of 2 quarters · filed 2016-11-10
$243.00K
10-Q · filed 2016-11-10
$2.07M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$118.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$612.00K
10-Q · filed 2016-08-11
$2.44M
derived: sum of 3 quarters · filed 2017-03-15
2015-03-31$494.00K
10-Q · filed 2016-05-12
$2.32M
derived: sum of 2 quarters · filed 2017-03-15
2014-12-31$1.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
$1.19M
10-K · filed 2017-03-15
-$1.19M
10-K · filed 2016-03-17
2014-09-30-$644.00K
10-Q · filed 2015-12-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79